Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults
Por:
Torres-Castro R., Otto-Yáñez M., Resqueti V.R., Roqué i Figuls M., Kline C.E., Fregonezi G.A.F., Vilaró J.
Publicada:
1 ene 2020
Resumen:
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. To assess the effectiveness of lifestyle modification or pharmacotherapy for weight loss for obstructive sleep apnoea in adults with overweight or obesity. Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Filiaciones:
Torres-Castro R.:
University of Chile, Department of Physical Therapy, Santiago, Chile
Otto-Yáñez M.:
Universidad Autónoma de Chile, School of Physical Therapy, Santiago, Chile
Resqueti V.R.:
Federal University of Rio Grande do Norte, PneumoCardioVascular Lab, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH) & Department of Physical Therapy, Campus Universitario Lagoa Nova, Caixa Postal 1524, Natal, Rio Grande do Norte 59078-970, Brazil
Roqué i Figuls M.:
CIBER Epidemiología y Salud Pública (CIBERESP), Iberoamerican Cochrane Centre, Biomedical Research Institute Sant Pau (IIB Sant Pau), Sant Antoni Maria Claret 171, Edifici Casa de Convalescència, Barcelona, Catalunya 08041, Spain
Kline C.E.:
University of Pittsburgh, Department of Health and Physical Activity, Pittsburgh, PA, United States
Fregonezi G.A.F.:
Federal University of Rio Grande do Norte, PneumoCardioVascular Lab, Onofre Lopes University Hospital, Brazilian Company of Hospital Services (EBSERH) & Department of Physical Therapy, Campus Universitario Lagoa Nova, Caixa Postal 1524, Natal, Rio Grande do Norte 59078-970, Brazil
Vilaró J.:
Ramon Lull University, Department of Health Sciences, Padilla, 326-332, Barcelona, 08025, Spain
|